Accolade to Participate in Upcoming Investor Conferences

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences:

• The 41st Annual William Blair Growth Stock Conference, including a fireside chat on Wednesday, June 2, 2021 at 9:00 a.m. E.T.
• The Goldman Sachs 42nd Annual Global Healthcare Conference, including a fireside chat on Tuesday, June 8, 2021 at 3:50 p.m. E.T.
• The Stifel 2021 Virtual Cross Sector Insight Conference including a presentation on Thursday, June 10, 2021 at 2:00 p.m. E.T.

The webcast links and related presentation materials will be available at ir.accolade.com.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians and access to expert medical opinion services for high-cost treatment decisions. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at www.accolade.com.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200, [email protected]

Asher Dewhurst, Investor Relations, 443-213-0500, [email protected]

Media Contact:

Megan Torres, Public Relations, 206-926-8180, [email protected]

Source: Accolade

You May Also Be Interested In

• Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
• Auctions of mortgage covered bonds series 10F and 10G for the refinancing of FlexLån®
• Etienna Bio Completes FDA INTERACT Meeting for ETB-001